Clinical Trials

Showing trials with last updates posted in 2026.

NCT06902480 | NOT_YET_RECRUITING | NA
24 participants

Dairy Choline Bioavailability

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2026-09-30
Completion:
2027-12-31
Conditions
  • Post-menopausal Women
  • Post-menopausal Status
Interventions
  • DIETARY_SUPPLEMENT
No Results Yet
NCT06788509 | ENROLLING_BY_INVITATION | PHASE1
120 participants

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2024-12-30
Completion:
2028-01-19
Conditions
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma, Non-Hodgkin
  • Myelodysplastic Syndromes
  • Neoplasms
  • Solid Tumor, Adult
  • Prostatic Neoplasms, Castration-Resistant
Interventions
  • DRUG
No Results Yet
NCT06784726 | RECRUITING | PHASE2
27 participants

Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2025-09-04
Completion:
2028-04-10
Conditions
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Recurrent Grade 3b Follicular Lymphoma
  • Recurrent High Grade B-Cell Lymphoma
  • Recurrent Primary Mediastinal Large B-Cell Lymphoma
  • Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Refractory Grade 3b Follicular Lymphoma
  • Refractory High Grade B-Cell Lymphoma
  • Refractory Primary Mediastinal Large B-Cell Lymphoma
  • Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Interventions
  • BIOLOGICAL
  • PROCEDURE
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page